Why the study?
Blockade of oxidative phosphorylation may activate mitoK(ATP) channels, but the protective effects of metabolic inhibition and mitoK(ATP) channel openers on ischemic injury and membrane currents require investigation.
Does preconditioning with metabolic inhibition or mitoK(ATP) channel opening reduce infarct size and alter surface membrane currents in isolated animal hearts and cells?
Does preconditioning with metabolic inhibition or mitoK(ATP) channel opening reduce infarct size and alter surface membrane currents in isolated animal hearts and cells?
Answers are grounded in this paper and cite their sources.
Preconditioning with metabolic inhibition or mitoK(ATP) channel opening protects the heart from ischemia and alters surface membrane currents, highlighting the role of mitoK(ATP) channels in myocardial protection.
BACKGROUND: Blockade of oxidative phosphorylation may activate ATP sensitive mitochondrial potassium (mitoK(ATP)) channels. We examined whether both metabolic inhibition and mitoK(ATP) channel openers protect both the whole organ and isolated cells from ischemia. METHODS AND RESULTS: Using a Langendorff preparation, one group of isolated rabbit hearts were exposed to ischemic preconditioning (IPC) via 2 episodes of flow interruption. The second group of hearts was preconditioned with 2 episodes of either the metabolic inhibitor, sodium cyanide (NaCN), or the mitoK(ATP) channel opener, diazoxide. The third group of hearts was exposed to the mitoK(ATP) channel inhibitor, 5-hydroxydecanoic acid (5-HD) prior to preconditioning with NaCN, diazoxide or IPC. Controls had no drug infused. Then, ischemia was induced in all hearts by left anterior descending coronary artery occlusion and infarct size was determined. Compared with controls (40+/-3%), infarct size was significantly reduced in hearts preconditioned with NaCN, diazoxide or IPC (18+/-3%, 26+/-3%, 21+/-2%, respectively; P<0.05 versus control). These reductions were reversed by 5-HD (36+/-3%, 33+/-2%, 37+/-2%; NaCN, diazoxide, IPC, respectively). Secondly, whole cell patch clamped isolated guinea pig ventricular myocytes were preconditioned with 2 episodes of either NaCN or diazoxide followed by Tyrodes perfusion with membrane potential set to -70 mV. Control cells were exposed to Tyrodes solution. All cells were then clamped to -20 mV and exposed to NaCN, which caused induction of an outward potassium current. Compared with controls, the average time to induction of the outward current was significantly reduced in cells preconditioned with either brief application of NaCN (11.6+/-1.8 versus 5.1+/-1.0 minutes, control versus NaCN, P<0.05) or diazoxide (5.5+/-1.4 versus 2.0+/-0.8 minutes, control versus diazoxide, P<0.05). CONCLUSIONS: Preconditioning protects the heart through mitoK(ATP). This protection also alters a surface membrane current, which may be important in myocardial protection.
No takes yet. Share an insight, caveat, or question.
Irie et al. (2003) studied Myocardial ischemia. Ischemic preconditioning, sodium cyanide, or diazoxide vs. Control (no drug infused) was evaluated on Infarct size (p=<0.05).
Synapse has enriched 10 related papers. Consider them for comparative context: